Your browser doesn't support javascript.
loading
Is IL-6 Back in trans Signaling for Inflammatory Bowel Disease?
Unger, Lukas W; Kaser, Arthur.
Affiliation
  • Unger LW; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre and, Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge and, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, UK.
  • Kaser A; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre and, Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge and, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, UK. Electronic address: ak729@cam.ac.uk.
Gastroenterology ; 160(7): 2247-2249, 2021 06.
Article in En | MEDLINE | ID: mdl-33753099
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Interleukin-6 Limits: Humans Language: En Journal: Gastroenterology Year: 2021 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Interleukin-6 Limits: Humans Language: En Journal: Gastroenterology Year: 2021 Document type: Article Affiliation country: United kingdom